Navigation Links
A Combined Research for Producing Chlamydia Vaccine Begins

Researchers at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and at San Antonio Health Science Center// (UTHSC) have come together in a combined effort to discover a vaccine that will prevent Chlamydia.

Chlamydia is a common sexually transmitted disease caused by the bacterium, Chlamydia trachomatis, which can damage a woman's reproductive organs. In women, symptoms are usually mild or absent. Serious complications can cause irreversible damage, including infertility, before a woman ever recognizes a problem.

The most recent report from the CDC indicates 930,000 cases of Chlamydial infection in the United States in 2004. The number of new cases of Chlamydia infection reported annually has risen to more than 2.8 million.

After three years of research, Ashlesh Murthy, a post-doctoral student in the UTSA Cell and Molecular Biology program has succeeded in obtaining a chlamydial prevention vaccine in mouse models. The next step will be to test the vaccine in larger animals, primarily guinea pigs.

'This is a very prevalent disease in women throughout the world and the biggest problem is that most infected women never show any symptoms, so they never get treated,' said Murthy. 'When Chlamydia is left untreated, it can lead to severe complications including pelvic-inflammatory disease, ectopic pregnancies and infertility.'

Bernard Arulanandam, an associate professor of biology who began studying Chlamydia six years ago, guides Murthy’s research.

'With the recent success of the human papilloma virus vaccine, developed to prevent cervical cancer in young women, I think the urgency to develop a Chlamydia prevention vaccine is on the horizon,' said Arulanandam. The UTSA researchers have been working with Guangming Zhong, a professor of microbiology at UTHSC, whose lab has been identifying antigens or proteins in Chlamydia as vaccine material and providing them for the UTSA rese
'"/>




Page: 1 2

Related medicine news :

1. Combined scan gives exact cancer diagnosis
2. A Protein-Rich Diet Combined With Exercise Found To Be More Effective In Weight Loss
3. Combined modality approach for effective treatment and enhanced survival in bile duct cancer
4. Vision Loss in Elderly Caused By Combined Effect of Genes and Bacterium
5. Exercise Combined with Dialysis Yields Better Results
6. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
7. A Combined Heart Pill-developed by Dr. Reddy’
8. Combined Ingredients may Cut Cholesterol Levels
9. Combined Imaging Approach may Provide Better Identification of Difficult-to-diagnose Brain Clots
10. Combined Imaging Approach may Be Effective in Diagnosing Some Brain Clots
11. Kidney Stones - Interesting New Research implicates bacteria as its cause

Post Your Comments:
(Date:11/30/2009)...nt to 113 chest X-rays, study finds , , ... of patients who have abdominal/pelvic CT scans re...pose them to extra radiation, U.S. researchers say...eries were performed on 500 patients aged 9 months...ears of age. The researchers concluded that 35.3 p...
(Date:11/30/2009)...unique online and mobile tool empowers patients to...isions ,, ARLINGTON, Va., Nov. 30 /PRNewswir...#1 HIV/AIDS resource online, today launched My Hea...V/AIDS-infected patients the ability to save, trac...d with sponsorship from Merck, is available at ww...
(Date:11/30/2009)...Nov. 30 Tyco Internation...10 annual general meeting of shareholders will be ...tral European time at the Park Hyatt Zurich Hotel,...egistered shareholders as of January 11, 2010 (the...al general meeting. Additionally, individuals who...
(Date:11/30/2009)... and extensive discussion in the scientific commun...ealth Care (IQWiG) presents its methods for evalua...stitute can now apply these methods when working o... Committee (G-BA). The method developed by IQWiG i...KV-Spitzenverband [National Association of Health ...
(Date:11/30/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Key Players and Innovative Start-Ups i...ts, pharma, food and drinks ,, http://www.rep...Start-Ups-in-Nutraceuticals-Emerging-strategies-in...traceuticals are bioactive compounds with properti...
Breaking Medicine News(10 mins):Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
...ver for those who prefer relaxing with a good cup ...ed by researchers from Charite Hospital Universita...European Heart Journal, has come out with a study ...hich protect the heart and have anti-cancer effect...
... in adolescents and young adults was associated wi...heart//, researchers report in Circulation: Journa...udy of American Indians, average age 26.5, those w... ventricular wall thickness, higher left ventricul...
...er week are at greater risk of developing osteoart...ccording to research conducted by the University o...is characterised by joint pain, which can be relie...s arose in the long-distance joggers' knees, said ...
...age healing through mantras! Sanskrit scholars of ...rsity// have initiated a research project, said to...es through Vedic chants. A state-of-the-art a...icipating in the research. The lab would inv...
... is a boon for the kith and kin of those people wh...vaccine is currently available in 33 countries all...rp & Dohme. This vaccine was formed by Professor I...g contender for Nobel Prize. In the middle E...
...California heaved a sigh of relief when the health...tween the meningitis// and the encephalitis cases ... have clearly indicated that the bacteria, which c...erial infection. An elementary school studen...
Other Medicine News:Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 2Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 3
(Date:11/30/2009)...L, Wash., Nov. 30 SCOLR ...at on November 25, 2009, the NYSE Amex LLC (the "E...d the Company,s plan to comply with its previously...)(iv) of the Exchange Company Guide. Specifically...stained losses which were so substantial in relati...
(Date:11/30/2009)...STON, S.C., Nov. 30 The Eleventh A...", will be held at the Charleston Place Hotel in t...r 3-4, 2009. Dr. Cheryl Liljestrand, Dr. Harry Gu...s with Stipkala LLC, will attend. SEBIO 2009 prom...nvestors, scientists, entrepreneurs, and service p...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Cardiac Defibrillat..., http://www.reportlinker.com/p0164315/Cardiac-De...ort.html ,, Cardiovascular disease (CVD) is o...den cardiac arrest survivors are prone to arrhythm...
Breaking Medicine Technology:SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 1International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 2International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 3International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 4International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 5International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 6International Isotopes Inc Announces Second Quarter and Six Months 2009 Financial Results 54312 7Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 1Cystic Fibrosis Foundation Receives Second 4 Star Rating from Charity Navigator for Exceptional Fiscal Management 54308 2
...S WIRE)--Apr 14, 2007 - In a late-breaker,presenta...sociation,for the Study of the Liver (EASL), resea... analysis of the PROVE 1 clinical trial,which is ... with,the investigational hepatitis C protease inh...h pegylated interferon (peg-IFN) and,ribavirin (RB...
...RNewswire-FirstCall/ -- ACCESS,PHARMACEUTICALS, IN...mechanism of ProLindac,s anticancer activity will ... Cancer Research (AACR) 2007,annual meeting in Los... two poster presentations describe preclinical stu...inent institutes in France. , "We are delighted to...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 2Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 3Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting 4
Silicone Wedge (137 Style)
Silicone Tire (281 Style)
Silicone Strip (225 Style)
Silicone Boat (60 Style)
Medicine Products: